Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
30 Noviembre 2021 - 5:06AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File Number: 001-40909 CUSIP Numbers:
79956P102; 79956P110; 79956P201
(Check
one): ¨ Form
10-K ¨ Form 20-F ¨ Form 11-K x
Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨
Form N-CSR
For
Period Ended: September 30, 2021
¨ Transition
Report on Form 10-K
¨ Transition
Report on Form 20-F
¨ Transition
Report on Form 11-K
¨ Transition
Report on Form 10-Q
For the Transition Period Ended:
Nothing in this form shall be construed to imply that
the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION
Sanaby Health Acquisition Corp. I
Full Name of Registrant
N/A
Former Name if Applicable
2625 Middlefield Road #990
Address of Principal Executive Office (Street and
Number)
Palo Alto, CA 94306
City, State and Zip Code
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
|
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
|
|
|
|
x
|
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or
portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be
filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
|
|
|
|
(c)
|
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F,
11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
Sanaby Health Acquisition Corp. I, a Delaware corporation
(the “Company”), has determined that it is unable to finalize its financial results without unreasonable expense
or effort. As a result, the Company could not solicit and obtain the necessary review of the Form 10-Q for the fiscal quarter ended September
30, 2021 (the “Q3 2021 Form 10-Q”).
The Company is working
diligently to complete the Q3 2021 Form 10-Q as soon as possible; however, the Company requires additional time to compile and
verify the data required to be included in the Q3 2021 Form 10-Q, and will be unable to complete and file the Q3 2021 Form 10-Q by the
required due date of November 29, 2021. The Company does, however, expect to file the Q3 2021 Form 10-Q within five calendar days thereof.
(1)
|
Name and telephone number of person to contact in regard to this notification.
|
|
Sandra Shpilberg
|
|
(415)
|
|
580-1810
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of
1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant
was required to file such report(s) been filed? If answer is no, identify report(s). Yes x
No ¨
|
|
|
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period
for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ¨
No x
|
|
|
|
If so, attach an explanation of the anticipated change,
both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
|
Sanaby
Health Acquisition Corp. I
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: November 29, 2021
|
|
By:
|
/s/ Sandra Shpilberg
|
|
|
|
Sandra Shpilberg
|
|
|
|
Chief Executive Officer
|
Sanaby Health Acquisitio... (NASDAQ:SANB)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Sanaby Health Acquisitio... (NASDAQ:SANB)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024